Categories: DesignDevelopment
Alpha Fusion Inc. is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals.
Investors 1
Mentions in press and media 2
| Date | Title | Description |
| 09.10.2024 | Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding | OSAKA, Japan, Oct. 9, 2024 /PRNewswire/ -- Alpha Fusion, Inc. (CEO: Sunao Fujioka, headquartered in Kita-ku, Osaka), has raised a total of ¥1.02 billion through a Series B funding round. The round was led by SBI Investment Co., Ltd. and OSA... |
| - | Alpha Fusion | “Alpha Fusion Inc. is a clinical-stage startup committed to transforming cancer treatment through the design and development of powerful and precise radiopharmaceuticals.” |
Reviews 0
